INTRODUCTION: The use of opioids in the United States has had an exponential growth
over that past decade. In 2001, Teichtahl described a high prevalence of sleep-disordered …

Background Rates of opioid overdose deaths are increasing in the United States, leading to
intensified efforts to provide medication-assisted treatments for opioid use disorders. It is not …

PURPOSE: Patients using chronic opioids are at risk for exceptionally complex and
potentially lethal disorders of breathing during sleep such as central or obstructive apneas …

Aside from respiratory suppression in overdose, full opioid agonist agents are known to
cause sleep-disordered breathing (SDB). The increasing rates of opioid overdose in the …

Patients using chronic opioids are at risk for exceptionally complex and potentially lethal
disorders of breathing during sleep, including central and obstructive apnoeas, hypopnoeas …

Preventing prescription opioid poisoning deaths is a major public health priority in Western
societies. Deaths from these medications exceed deaths from all illicit drugs combined [1] …

Opioids are used widely as analgesics and can play an important role in agonist
maintenance therapy for opium dependence. Despite their benefits, the negative effects on …

Introduction It has been well documented that opiate use is a risk factor for developing sleep
apnea. We suspect that buprenorphine being a partial-opioid-agonist to also be a risk factor …

Introduction Subjects on methadone maintenance for drug addiction have been reported to
have central sleep apnea (CSA). However, there are few reports of disordered breathing in …

The optimal therapy of chronic opioid induced sleep disordered breathing (SDB) is unclear.
Supplemental oxygen may potentially prolong central apneas and increase respiratory …